Drug Coated Balloon Angioplasty in Failing AV Fistulae: A Randomized Controlled Trial.
CONCLUSIONS: Paclitaxel-coated balloon-assisted angioplasty did not meet the primary effectiveness end point at 180 days compared with conventional angioplasty. Both arms showed equivalent safety (ClinicalTrials.gov number NCT02440022).
PMID: 30042225 [PubMed - as supplied by publisher]
Source: Clinical Journal of the American Society of Nephrology : CJASN - Category: Urology & Nephrology Authors: Trerotola SO, Lawson J, Roy-Chaudhury P, Saad TF, Lutonix AV Clinical Trial Investigators Tags: Clin J Am Soc Nephrol Source Type: research
More News: Angioplasty | Baloon Angioplasty | Central Venous Catheterization | Clinical Trials | Dialysis | Hemodialysis | Legislation | Urology & Nephrology